Roche infectious news

Roche said India's Chennai Patent Office rejected Roche's Indian Patent No. IN207232 covering Valcyte valganciclovir because it was not considered an invention under India's patent laws and also lacked an inventive step. The patent covers mono-L-valine ester of valganciclovir and a process for its preparation. Roche said it is considering an appeal to the Intellectual Property Appellate Board (IPAB). ...